John Chopack Jr.

John Chopack Jr. is a strategic MedTech business development and investment leader with more than 25 years of experience spanning orthopedics, dental, surgical robotics, biologics, and enabling-technology sectors. He has built a uniquely multidisciplinary career—beginning in the operating room, advancing through Wall Street equity research, and culminating in leadership roles in private equity, venture capital, and global operations.

John is recognized for his ability to identify high-growth opportunities, lead complex M&A and capital-formation initiatives, and execute operational turnarounds that unlock shareholder value. His approach merges investor-level discipline with operator level execution aligning strategic, clinical, and financial goals to drive sustainable growth and improved patient outcomes.

Career Highlights

  • Cross-Functional MedTech Expertise: Experience across orthopedic implants, dental devices, surgical robotics, biologics, and digital-enabling technologies.

  • Investment & M&A Leadership: Originated, structured, and executed over $190 million in growth financings and 8 strategic acquisitions across early and growth-stage MedTech platforms resulting in

  • Global Expansion Expertise: Led international licensing, distribution, and private-label partnerships to scale MedTech platforms globally.

  • Deep Industry Relationships: Two decades of trusted partnerships with surgeons, executives, investors, and strategic acquirers across the MedTech landscape.

  • Board & Governance Experience: Served on boards and committees including BioHorizons Inc., Blue Belt Technologies, OrthoSpace, Benvenue Medical, TriAgenics, and Nexa Orthopedics.

Notable Transactions

  • Blue Belt Technologies → Smith & Nephew: Originated and managed investment in a pioneering surgical-robotics platform, culminating in a $275 million acquisition.

  • BioHorizons → Henry Schein: Consolidated three dental-implant companies into a market-leading platform with a successful exit to an industry leader.

  • Nexa Orthopedics → Tornier (Stryker): Formed and integrated four orthopedic extremity businesses into a strategic platform sold for $72.5 million.

  • TriAgenics: Structured seed capital for a minimally invasive dental surgery technology targeting a transformative FDA-cleared procedure.

  • Global Expansion & Partnerships: Negotiated private-label supply and international distribution agreements across Europe, Asia, and North America.

Expertise & Focus Areas

  • Orthopedics & Extremity Surgery

  • Dental Implant & Regenerative Technologies

  • Surgical Robotics & Navigation Systems

  • Biologics & Regenerative Medicine

  • Enabling Digital & AI-Driven Health Technologies

  • M&A, Licensing & Partnership Strategy

  • Capital Formation & Investor Relations

  • Operational Turnarounds & Global Expansion

  • Board Advisory & Governance Leadership